AzTrials
AzTrials

DepressionNCT00717041

Epidemiology of Depression, Anxiety, and Cognitive Impairment

An observational study of Depression and Anxiety, run by University of Rochester at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Depression, Anxiety, Cognitive Impairment
How many people
1,206 participants
Where
1 siteUnited States
Study dates
May 2008to Feb 2009
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All older adults arriving at participating hospital emergency departments to obtain emergency care.

Who may be able to join

  • Age 60 and older
  • Arrival at ED

Who cannot join

  • Institutionalized

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Rochester

    Rochester, New York, 14646

Other trials in United States

About this study

Official title: Epidemiology of Depression, Anxiety, and Cognitive Impairment Among Emergency Department Patients

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise.

The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.

Read the detailed description

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise.

The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. This study aims to:

  1. Compare the prevalence of depression and cognitive impairment among patients who arrive at the ED by EMS, as compared to those arriving via other means.
  2. Evaluate the reliability of screening patients for depression and cognitive impairment during an acute illness and after the illness.
  3. To evaluate correlates of depression, anxiety and suicidal ideation. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.
Keywords
Depression, Anxiety, Cognitive Impairment, Emergency medicine, prehospital care
Medical subject headings
Depression, Anxiety Disorders, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00717041
Study groupRoleWhat they receive
Presenting to the EDPatients who present to the ED

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participants With Depression by Patient Health Questionnaire - 9

    Number of participants with depression as measured by the Patient Health Questionnaire - 9, with a score of greater than or equal to 10.

    Measured: 2 hours

  2. Participants With Cognitive Impairment by Six Item Screener

    Number of participants with cogintiive impairment as measured by the Six Item Screener, with greater than 2 questions incorrect

    Measured: 2 hours

  3. Participants With Anxiety by Generalized Anxiety Disorder - 7

    Participants with anxiety as measured by the Generalized Anxiety Disorder - 7, with a score greater than or equal to 10.

    Measured: 2 hours

Secondary outcomes (1)
  1. Depression and Cognitive Impairment at 2 Weeks

    For the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2008 (estimated)
  2. Study startMay 2008
  3. Primary completionSep 2008
  4. Study completionFeb 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,206 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00717041
Sponsor's protocol ID
RSRB 24085
Other IDs
NIH 5K23AG028942
Status last verified
Jun 2015
First submitted
14 Jul 2008
Last updated
15 Jun 2015
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression and Anxiety, run by University of Rochester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Jun 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participants With Depression by Patient Health Questionnaire - 9 (time frame: 2 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in